WO2024176175 - METHODS OF TREATING ATOPIC DERMATITIS
National phase entry:
Publication Number
WO/2024/176175
Publication Date
29.08.2024
International Application No.
PCT/IB2024/051737
International Filing Date
22.02.2024
Title **
[English]
METHODS OF TREATING ATOPIC DERMATITIS
[French]
MÉTHODES DE TRAITEMENT DE LA DERMATITE ATOPIQUE
Applicants **
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Inventors
BUIL-BRUNA, Nuria
SCOTT, Robert A.
UINGS, Iain J.
Priority Data
63/486,752
24.02.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2602 | |
| EPO | Filing, Examination, Granting | 18375 | |
| Japan | Filing, Examination, Granting | 2855 | |
| South Korea | Filing, Examination, Granting | 3521 | |
| USA | Filing, Examination, Granting | 7540 |
Total:
34,893
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The disclosure provides a method of treating atopic dermatitis in a human subject by the administration of certain anti-IL-18 antibodies. The disclosure also provides uses of certain anti- IL-18 antibodies in the treatment of atopic dermatitis in a human subject.[French]
L'invention concerne une méthode de traitement de la dermatite atopique chez un sujet humain par l'administration de certains anticorps anti-IL-18. L'invention concerne également des utilisations de certains anticorps anti-IL-18 dans le traitement de la dermatite atopique chez un sujet humain.